Citadel Advisors’s Immuron IMRN Stock Holding History
Bought
Maintained
Sold
Other funds holding IMRN
XT
TSS
Citadel Advisors's IMRN Position: Q1 2026 in Review
Citadel Advisors reduced its Immuron (IMRN) stake by 70% in Q1 2026, selling an estimated $26.6K and leaving 13,804 shares worth $10.7K. The position accounts for ﹤0.01% of the portfolio, ranked #12749.
Citadel Advisors first reported a position in IMRN in Q4 2022 and has held it in 5 quarters since. The position peaked at $96.9K in Q4 2022. 7 funds tracked by Wall St. Rank hold IMRN as of Q1 2026.
- Citadel Advisors held 13,804 shares of Immuron worth $10.7K as of Q1 2026.
- Citadel Advisors sold 31,978 Immuron shares in Q1 2026, an estimated $26.6K.
- Immuron made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #12749 holding.
- Citadel Advisors first reported a position in Immuron in Q4 2022 and has held it in 5 quarters since.
- Citadel Advisors's Immuron position peaked at $96.9K in Q4 2022.
- 7 funds tracked by Wall St. Rank held Immuron as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.